Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Four peptide hormones decrease the number of human breast adenocarcinoma cells.

B A Vesely1, S Song, J Sanchez-Ramos

  • 1Department of Biochemistry and Molecular Biology, University of South Florida Cardiac Hormone Center and James A. Haley Veteran's Administration Medical Center, Tampa, FL, USA.

European Journal of Clinical Investigation
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics of <i>HTT</i> lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle.

Journal of drug delivery science and technology·2021
Same author

The expression of the transcription factor TAF1 is modified by the HPV16 E2 protein.

Acta virologica·2020
Same author

Human Umbilical Cord Cells Express Neural Markers after Transplantation into Subventricular Zone of the DevelopingRat Brain.

Cell transplantation·2017
Same author

Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.

The International journal of neuroscience·2011
Same author

Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

European journal of clinical investigation·2010
Same author

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Neuroscience·2009
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Four natriuretic peptides, including vessel dilator, significantly reduced breast cancer cell counts and proliferation by inhibiting DNA synthesis and decreasing S-phase cells. These findings highlight potential therapeutic applications for natriuretic peptides in breast cancer treatment.

Area of Science:

  • Endocrinology
  • Oncology
  • Cell Biology

Background:

  • Natriuretic peptides are a family of six hormones known for regulating sodium and water balance and blood pressure.
  • Their potential anti-cancer properties, particularly against breast adenocarcinoma, were largely unexplored.

Purpose of the Study:

  • To investigate the effects of six natriuretic peptides on the proliferation and viability of human breast adenocarcinoma cells in vitro.
  • To determine the mechanism of action, including effects on DNA synthesis and cell cycle progression.

Main Methods:

  • Human breast adenocarcinoma cells were cultured and treated with 1-micromolar concentrations of six natriuretic peptides for 24, 48, 72, and 96 hours.
  • Cell number, proliferation, DNA synthesis, and cell cycle distribution (S phase) were assessed.

Related Experiment Videos

  • Expression of natriuretic peptide receptors A and C was confirmed.

    • Main Results:

    • Vessel dilator, long-acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide significantly decreased breast adenocarcinoma cell number within 24 hours.
    • These four peptides also inhibited DNA synthesis and reduced the percentage of cells in the S phase of the cell cycle.
    • Brain natriuretic peptide and C-natriuretic peptide did not exhibit significant anti-proliferative effects.

    Conclusions:

    • Four specific natriuretic peptides demonstrate significant anti-proliferative effects on human breast adenocarcinoma cells.
    • The mechanism involves the inhibition of DNA synthesis and a reduction in S-phase cells, partly mediated by cyclic GMP.
    • These findings suggest a potential therapeutic role for certain natriuretic peptides in managing breast cancer.